Max Healthcare Institute Ltd (MAXHEALTH) Stock Forecast & Price Target

Compare

8 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MAXHEALTH Analyst Ratings

Moderate Buy

1 Buy

0 Hold

0 Sell

Based on 1 analysts giving stock ratings to

Max

Healthcare Institute Ltd

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MAXHEALTH Stock 12 Month Forecast

Average Price Target

₹1,325.00

▲(10.20% Upside)

Based on 1 Wall Street analysts offering 12 month price targets for Max Healthcare Institute Ltd in the last 3 months. The average price target is ₹1,325.00 with a high forecast of ₹1,325.00 and a low forecast of ₹1,325.00. The average price target represents a 10.20% change from the last price of ₹1,202.35.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"976":"₹976","1151":"₹1,151","1326":"₹1,326","1063.5":"₹1,063.5","1238.5":"₹1,238.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.32K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.32K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.32K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[976,1063.5,1151,1238.5,1326],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1048.6,1069.8615384615384,1091.123076923077,1112.3846153846152,1133.6461538461538,1154.9076923076923,1176.1692307692308,1197.430769230769,1218.6923076923076,1239.9538461538461,1261.2153846153847,1282.476923076923,1303.7384615384615,{"y":1325,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1048.6,1069.8615384615384,1091.123076923077,1112.3846153846152,1133.6461538461538,1154.9076923076923,1176.1692307692308,1197.430769230769,1218.6923076923076,1239.9538461538461,1261.2153846153847,1282.476923076923,1303.7384615384615,{"y":1325,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1048.6,1069.8615384615384,1091.123076923077,1112.3846153846152,1133.6461538461538,1154.9076923076923,1176.1692307692308,1197.430769230769,1218.6923076923076,1239.9538461538461,1261.2153846153847,1282.476923076923,1303.7384615384615,{"y":1325,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1138.24,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1061.02,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":977.72,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1082.25,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1094.94,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1149.07,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1278.12,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1246.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1179.65,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1112.55,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1147.75,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1124.45,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1048.6,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target₹1,325

Average Price Target₹1,325

Lowest Price Target₹1,325

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Shyam Srinivasan

Goldman Sachs

₹1,325

Buy

10.20%

Upside

Initiated

12/07/25

Unknown Analyst

Geojit Research

Not Ranked

Geojit Research

₹1,240→₹1,280

Hold

6.46%

Upside

Downgraded

09/02/25

Geojit Research downgrades Max Healthcare Institute Ltd (MAXHEALTH) to a Hold

Alankar Garude

Kotak Mahindra

₹1,070→₹1,140

Sell

-5.19%

Downside

Reiterated

08/18/25

Kotak Mahindra Remains a Sell on Max Healthcare Institute Ltd (MAXHEALTH)

Alok Dalal

Jefferies

₹1,400→₹1,500

Buy

24.76%

Upside

Reiterated

08/14/25

Max Healthcare Institute Ltd (MAXHEALTH) Gets a Buy from Jefferies

Vivek Agrawal CFA

Citi

₹1,250→₹1,460

Buy

21.43%

Upside

Reiterated

08/11/25

Citi Remains a Buy on Max Healthcare Institute Ltd (MAXHEALTH)

Damayanti Kerai

HSBC

₹1,055→₹1,145

Hold

-4.77%

Downside

Reiterated

07/17/25

HSBC Sticks to Its Hold Rating for Max Healthcare Institute Ltd (MAXHEALTH)

Bansi Desai

J.P. Morgan

₹1,390→₹1,325

Buy

10.20%

Upside

Reiterated

05/22/25

Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,325 at JPMorganJPMorgan analyst Bansi Desai lowered the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,325.00 (from INR1,390.00) while maintaining a Overweight rating.

Neha Manpuria

Bank of America Securities

₹1,100→₹1,170

Hold

-2.69%

Downside

Reiterated

05/21/25

Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,170 at BofA SecuritiesBofA Securities analyst Neha Manpuria raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,170.00 (from INR1,100.00) while maintaining a Neutral rating.

Kunal Dhamesha

Macquarie

₹615

Sell

-48.85%

Downside

Reiterated

03/28/25

Macquarie Reiterates Underperform Rating on Max Healthcare Institute Ltd (MAXHEALT:IN)Macquarie analyst Kunal Dhamesha reiterated an Underperform rating and INR615.00 price target on Max Healthcare Institute Ltd (MAXHEALT:IN).

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Shyam Srinivasan

Goldman Sachs

₹1,325

Buy

10.20%

Upside

Initiated

12/07/25

Unknown Analyst

Geojit Research

Not Ranked

Geojit Research

₹1,240→₹1,280

Hold

6.46%

Upside

Downgraded

09/02/25

Geojit Research downgrades Max Healthcare Institute Ltd (MAXHEALTH) to a Hold

Alankar Garude

Kotak Mahindra

₹1,070→₹1,140

Sell

-5.19%

Downside

Reiterated

08/18/25

Kotak Mahindra Remains a Sell on Max Healthcare Institute Ltd (MAXHEALTH)

Alok Dalal

Jefferies

₹1,400→₹1,500

Buy

24.76%

Upside

Reiterated

08/14/25

Max Healthcare Institute Ltd (MAXHEALTH) Gets a Buy from Jefferies

Vivek Agrawal CFA

Citi

₹1,250→₹1,460

Buy

21.43%

Upside

Reiterated

08/11/25

Citi Remains a Buy on Max Healthcare Institute Ltd (MAXHEALTH)

Damayanti Kerai

HSBC

₹1,055→₹1,145

Hold

-4.77%

Downside

Reiterated

07/17/25

HSBC Sticks to Its Hold Rating for Max Healthcare Institute Ltd (MAXHEALTH)

Bansi Desai

J.P. Morgan

₹1,390→₹1,325

Buy

10.20%

Upside

Reiterated

05/22/25

Neha Manpuria

Bank of America Securities

₹1,100→₹1,170

Hold

-2.69%

Downside

Reiterated

05/21/25

Kunal Dhamesha

Macquarie

₹615

Sell

-48.85%

Downside

Reiterated

03/28/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Max Healthcare Institute Ltd

3 Months

xxx

Success Rate

2/2 ratings generated profit

Average Return

+5.30%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.30% per trade.

1 Year

Alankar GarudeKotak Mahindra

Success Rate

3/3 ratings generated profit

Average Return

+10.67%

reiterated a sell rating 6 months ago

Copying Alankar Garude's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +10.67% per trade.

2 Years

xxx

Success Rate

3/3 ratings generated profit

Average Return

+12.47%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.47% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MAXHEALTH Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MAXHEALTH has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MAXHEALTH average Analyst price target in the past 3 months is 1,325.00.

Each month's total comprises the sum of three months' worth of ratings.

MAXHEALTH Financial Forecast

MAXHEALTH Earnings Forecast

Next quarter’s earnings estimate for MAXHEALTH is ₹3.96 with a range of ₹3.46 to ₹4.80. The previous quarter’s EPS was ₹5.02. MAXHEALTH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.

MAXHEALTH Sales Forecast

Next quarter’s sales forecast for MAXHEALTH is ₹25.31B with a range of ₹23.66B to ₹27.13B. The previous quarter’s sales results were ₹21.35B. MAXHEALTH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.

MAXHEALTH Stock Forecast FAQ

What is IN:MAXHEALTH’s average 12-month price target, according to analysts?

Based on analyst ratings, Max Healthcare Institute Ltd’s 12-month average price target is 1,325.00.

What is IN:MAXHEALTH’s upside potential, based on the analysts’ average price target?

Max Healthcare Institute Ltd has 10.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Max Healthcare Institute Ltd a Buy, Sell or Hold?

Max Healthcare Institute Ltd has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.

What is Max Healthcare Institute Ltd’s share price target?

The average share price target for Max Healthcare Institute Ltd is 1,325.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹1,325.00 ,and the lowest forecast is ₹1,325.00. The average share price target represents 10.20% Increase from the current price of ₹1,202.35.

What do analysts say about Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of Max Healthcare Institute Ltd?

To buy shares of IN:MAXHEALTH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Max Healthcare Institute Ltd (MAXHEALTH) Stock Forecast & Price Target

MAXHEALTH Analyst Ratings

MAXHEALTH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Max Healthcare Institute Ltd

MAXHEALTH Analyst Recommendation Trends

MAXHEALTH Financial Forecast

MAXHEALTH Earnings Forecast

MAXHEALTH Sales Forecast

MAXHEALTH Stock Forecast FAQ

Detailed List of Analyst Forecasts